Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20417Recruiting
Randomised, double-blind trial in recurrent miscarriage (RPL) and autoimmune thyroid disease (AITD) comparing Levothyroxine with Placebo (2 arms). Primary endpoint: Live birth beyond 24 weeks. Started Feb 2013; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20417.